New CF Patient Subset For Vertex With Kaftrio's EU Approval
Opportunity Opens Following EU Approval Of Triple Combination
EU approval came quicker than expected for Vertex’s new triple-combination CFTR drug, Kaftrio.
EU approval came quicker than expected for Vertex’s new triple-combination CFTR drug, Kaftrio.